1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023

EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023

Summary

Allergic conjunctivitis is an inflammation of the eye resulting from an allergic reaction to allergy causing substances (external antigens) like pollen, dander, mold, or other substances. In allergic conjunctivitis, the conjunctiva - a layer of tissue which lines the front part of the eyeball (the white part of the eye) and the inside of the eyelids is inflamed secondary to an immune response to external antigens, usually called allergens. Allergic conjunctivitis is one of the most common eye problems encountered in general ophthalmic practices.

GlobalData epidemiologists forecast that the total prevalent cases of allergic conjunctivitis in the 6MM will grow by 5.40% over the next decade, from 155,455,174 total prevalent cases in 2013 to 163,925,356 total prevalent cases in 2023, with almost 50% of the total prevalent cases occurring in the US alone.

GlobalData’s epidemiological analysis is supported by the use of total prevalence data from epidemiological studies published in peer-reviewed journals. GlobalData’s epidemiological analysis included the most recently published studies that provided the total prevalence of allergic conjunctivitis based on self-reported symptoms. GlobalData epidemiologists used uniform methodology across the markets to forecast the total prevalent cases of allergic conjunctivitis which allows for a meaningful comparison of disease populations between markets.

Scope

- The Allergic Conjunctivitis EpiCast Report provides an overview of the risk factors, comorbidities, and global and historical trends for allergic conjunctivitis in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiological forecast for total one-year prevalent cases of allergic conjunctivitis segmented by sex and age (0-14 years, 15-34 years, 35-54 years, 55-74 years, and =75 years) in these markets.
- The allergic conjunctivitis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global allergic conjunctivitis market.
- Quantify patient populations in the global allergic conjunctivitis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for allergic conjunctivitis therapeutics in each of the markets covered.

Table Of Contents

EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023
1 Table of Contents

2 Introduction 6
2.1 Catalyst 6
2.2 Related Reports 7
2.3 Upcoming Reports 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 9
3.3 Global Trends 10
3.4 Forecast Methodology 11
3.4.1 Sources Used 12
3.4.2 Forecast Assumptions and Methods 14
3.5 Epidemiological Forecast for Allergic Conjunctivitis (2013-2023) 15
3.5.1 Total Prevalent Cases of Allergic Conjunctivitis 15
3.5.2 Age-Specific Total Prevalent Cases of Allergic Conjunctivitis 17
3.5.3 Sex-Specific Total Prevalent Cases of Allergic Conjunctivitis 18
3.6 Discussion 20
3.6.1 Epidemiological Forecast Insight 20
3.6.2 Limitations of the Analysis 21
3.6.3 Strengths of the Analysis 22
4 Appendix 23
4.1 Bibliography 23
4.2 About the Authors 25
4.2.1 Epidemiologists 25
4.2.2 Reviewers 25
4.2.3 Director of Epidemiology 26
4.2.4 Global Head of Healthcare 27
4.3 About GlobalData 28
4.4 About EpiCast 28
4.5 Disclaimer 29

1.1 List of Tables

Table 1: Risk Factors and Comorbidities for Allergic Conjunctivitis 10
Table 2: 6MM, Sources of Allergic Conjunctivitis Prevalence Data Used in the Epidemiology Forecast 12
Table 3: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, All Ages, Both Sexes, N, 2013-2023 16
Table 4: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, by Age, Both Sexes, N (Row %), 2013 17
Table 5: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, by Sex, All Ages, N (Row %), 2013 19

1.2 List of Figures

Figure 1: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, All Ages, Both Sexes, N, 2013-2023 16
Figure 2: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, by Age, Both Sexes, N, 2013-2023 18
Figure 3: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, by Sex, All Ages, N, 2013 20

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Cardiovascular Surgical Devices: Technologies and Global Markets

Cardiovascular Surgical Devices: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about the trends and developments affecting each type of cardiovascular surgical technology - Analyze trends and opportunities in major regions: North America, Europe, Asia ...

TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.